Accelerated Early Antibody Discovery Workflows – Label-free, Fluidic-free, Stress-free

Learning Objectives:

• Improve the overall drug discovery process to increase the success rate of preclinical candidates

• Identify elite candidates earlier in screening

• Use a fluidic-free, label-free approach in high-throughput, high-resolution screening for selection of lead candidates in real-time

• Presentation of comparisons across platforms, including traditional ELISA, flow cytometry, surface plasmon resonance (SPR), and in vivo studies